U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula Fe
Molecular Weight 55.845
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 2

SHOW SMILES / InChI
Structure of FERROUS CATION

SMILES

[Fe++]

InChI

InChIKey=CWYNVVGOOAEACU-UHFFFAOYSA-N
InChI=1S/Fe/q+2

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/3541174 | https://books.google.ru/books?id=7mxyBgAAQBAJ&pg=PA13&lpg=PA13&dq=%22ferrous+iodide%22+anemia&source=bl&ots=ZGyFhUiJZ4&sig=IZOhRVaGmlwX7GcqgoE6rnCsCa4&hl=ru&sa=X&ved=0ahUKEwjYu7PCyYHUAhWiQpoKHR6cCfcQ6AEIUjAJ#v=onepage&q=%22ferrous%20iodide%22&f=false

There is no information about biological and pharmacological application of Iron(II) fluoride (also known as ferrous fluoride). It is known, that this substance is used to catalyze some organic reactions.

Originator

Approval Year

1921
1468
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Not Provided
511
Unknown

Approved Use

Unknown
Palliative
Not Provided
511
Unknown

Approved Use

Unknown
Primary
Approved
8583
Ferro Sanol Duodenal

Approved Use

Ferro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia.
Curative
Approved
8583
RADIOGARDASE

Approved Use

Insoluble Prussian blue is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination.

Launch Date

2003
PubMed

PubMed

TitleDatePubMed
FERROUS IODIDE AND LINOLEIC ACID IN VITAMIN A DEFICIENCY. A REPLY TO CERTAIN CRITICISMS.
1932 Nov 11
THE USE OF FERROUS GLUCONATE IN THE TREATMENT OF HYPOCHROMIC ANEMIA.
1937 Jul
[Ferrous lactate as an oral iron preparation for therapeutic use].
1954 Nov 27
[FERROUS ASPARTATE IN THERAPY].
1964 Jan 1
Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis.
2007
The effect of iron treatment on adhesion molecules in patients with iron deficiency anemia.
2010 Dec
Tolerability of different oral iron supplements: a systematic review.
2013 Apr
A practical and successful desensitization protocol for immediate hypersensitivity reactions to iron salts.
2014
Synthesis of phosphabenzenes by an iron-catalyzed [2+2+2] cycloaddition reaction of diynes with phosphaalkynes.
2015 Jun 22
Reactivity enhancement of iron sulfide nanoparticles stabilized by sodium alginate: Taking Cr (VI) removal as an example.
2017 Jul 5
Atomic Layer Deposition of Iron Sulfide and Its Application as a Catalyst in the Hydrogenation of Azobenzenes.
2017 Mar 13
Continuous sulfidogenic wastewater treatment with iron sulfide sludge oxidation and recycle.
2017 May 1
Patents

Patents

CN105565963
37
US20020127665
37
US2009028810
37
US20150202224
37
US2877253
37
US3091626
37
US5534268
37
US6407138
37
US8080520
37
US8802114
37

Sample Use Guides

In Vivo Use Guide
Adults should usually take one capsule a day. In cases of pronounced iron deficiency, adults can be given a dosage 2 to 3 times higher at the beginning of therapy. A daily dose of more than 5 mg Fe2+/kg body weight should in-well founded exceptional cases not be exceeded.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
FE2+
Preferred Name English
FERROUS CATION
Common Name English
IRON(2+) ION
Common Name English
IRON, ION (FE2+)
Common Name English
IRON(II) ION
Common Name English
FERROUS ION
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID4042672
Created by admin on Mon Mar 31 19:56:54 GMT 2025 , Edited by admin on Mon Mar 31 19:56:54 GMT 2025
PRIMARY
RXCUI
1541238
Created by admin on Mon Mar 31 19:56:54 GMT 2025 , Edited by admin on Mon Mar 31 19:56:54 GMT 2025
PRIMARY RxNorm
EVMPD
SUB21940
Created by admin on Mon Mar 31 19:56:54 GMT 2025 , Edited by admin on Mon Mar 31 19:56:54 GMT 2025
PRIMARY
SMS_ID
100000085229
Created by admin on Mon Mar 31 19:56:54 GMT 2025 , Edited by admin on Mon Mar 31 19:56:54 GMT 2025
PRIMARY
CHEBI
29033
Created by admin on Mon Mar 31 19:56:54 GMT 2025 , Edited by admin on Mon Mar 31 19:56:54 GMT 2025
PRIMARY
PUBCHEM
27284
Created by admin on Mon Mar 31 19:56:54 GMT 2025 , Edited by admin on Mon Mar 31 19:56:54 GMT 2025
PRIMARY
DAILYMED
GW89581OWR
Created by admin on Mon Mar 31 19:56:54 GMT 2025 , Edited by admin on Mon Mar 31 19:56:54 GMT 2025
PRIMARY
CAS
15438-31-0
Created by admin on Mon Mar 31 19:56:54 GMT 2025 , Edited by admin on Mon Mar 31 19:56:54 GMT 2025
PRIMARY
FDA UNII
GW89581OWR
Created by admin on Mon Mar 31 19:56:54 GMT 2025 , Edited by admin on Mon Mar 31 19:56:54 GMT 2025
PRIMARY
DRUG BANK
DB14510
Created by admin on Mon Mar 31 19:56:54 GMT 2025 , Edited by admin on Mon Mar 31 19:56:54 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of FERROUS CATION
SALT/SOLVATE (PARENT)
Structure of FERROUS NITRATE HEXAHYDRATE
SALT/SOLVATE (PARENT)
Structure of FERROUS CHLORIDE
SALT/SOLVATE (PARENT)
Structure of FERROTRENINE
SALT/SOLVATE (PARENT)
Structure of FERROUS GLUCONATE
SALT/SOLVATE (PARENT)
Structure of FERROUS SULFIDE
SALT/SOLVATE (PARENT)
Structure of OLIVINE
SALT/SOLVATE (PARENT)
Structure of FERROUS OXALATE DIHYDRATE
SALT/SOLVATE (PARENT)
Structure of FERROUS HYDROXIDE
SALT/SOLVATE (PARENT)
Structure of FERROUS NICOTINATE
SALT/SOLVATE (PARENT)
Structure of FERROHEME
SALT/SOLVATE (PARENT)
Structure of FERROUS BISGLYCINATE
SALT/SOLVATE (PARENT)
Structure of SODIUM NITROPRUSSIDE
SALT/SOLVATE (PARENT)
Structure of FERROUS BROMIDE
SALT/SOLVATE (PARENT)
Structure of FERROUS OXIDE
SALT/SOLVATE (PARENT)
Structure of HEKLA LAVA
SALT/SOLVATE (PARENT)
Structure of FERROUS GLUCONATE ANHYDROUS
SALT/SOLVATE (PARENT)
Structure of FERROUS CITRATE
SALT/SOLVATE (PARENT)
Structure of FERROUS GLUTAMATE
SALT/SOLVATE (PARENT)
Structure of HEME L
SALT/SOLVATE (PARENT)
Structure of FERROUS SULFATE
SALT/SOLVATE (PARENT)
Structure of FERROUS ARSENATE
SALT/SOLVATE (PARENT)
Structure of FERROUS CARBONATE
SALT/SOLVATE (PARENT)
Structure of FERRIC FERROCYANIDE
SALT/SOLVATE (PARENT)
Structure of FERROUS FUMARATE
SALT/SOLVATE (PARENT)
Structure of FERROUS GLUCEPTATE
SALT/SOLVATE (PARENT)
Structure of FERROUS OXALATE
SALT/SOLVATE (PARENT)
Structure of FERROUS SELENIDE
SALT/SOLVATE (PARENT)
Structure of FERROUS ASPARTATE
SALT/SOLVATE (PARENT)
Structure of HEME ARGINATE
SALT/SOLVATE (PARENT)
Structure of FERROUS THIOCYANATE
SALT/SOLVATE (PARENT)
FERRUM PHOSPHORICUM
SALT/SOLVATE (PARENT)
Structure of FERROUS SULFATE MONOHYDRATE
SALT/SOLVATE (PARENT)
Structure of FERROUS DIASPARTATE
SALT/SOLVATE (PARENT)
Structure of FERROUS HYPOPHOSPHITE
SALT/SOLVATE (PARENT)
Structure of FERROUS FLUORIDE
SALT/SOLVATE (PARENT)
Structure of FERRIC SODIUM FERROCYANIDE
SALT/SOLVATE (PARENT)
Structure of FERROUS TARTRATE
SALT/SOLVATE (PARENT)
Structure of SODIUM FERROCYANIDE
SALT/SOLVATE (PARENT)
Structure of FERROUS IODIDE
SALT/SOLVATE (PARENT)
Structure of FERROCENE
SALT/SOLVATE (PARENT)
Structure of FERROUS CALCIUM CITRATE
SALT/SOLVATE (PARENT)
Structure of FERROGLYCINE SULFATE
SALT/SOLVATE (PARENT)
Structure of FERROUS SULFATE ANHYDROUS
SALT/SOLVATE (PARENT)
Structure of FERROSOFERRIC OXIDE
SALT/SOLVATE (PARENT)
Structure of FERROUS SUCCINATE
SALT/SOLVATE (PARENT)
Structure of POTASSIUM FERROCYANIDE
SALT/SOLVATE (PARENT)
Structure of FERROSOFERRIC PHOSPHATE
SALT/SOLVATE (PARENT)
Structure of FERROTRENINE ANHYDROUS
SALT/SOLVATE (PARENT)
Structure of FERROQUINE
SALT/SOLVATE (PARENT)
Structure of FERROUS ASPARTO GLYCINATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966